Congenital heart disease trials in Austria

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Austria
  Cangrelor safety and pharmacodynamics in paediatric subjects with congenital heart disease

  Where

  Graz, Vienna

  Age

  Up to 17 years

  People

  60 worldwide

  Run by

  Chiesi Farmaceutici S.p.A.

  See details and how to join2025-523109-14-00
• No phaseTaking people
  Effect of Fetal Aortic Valvuloplasty on Outcomes

  Where

  Linz

  Age

  23 weeks to 31 weeks

  People

  200 worldwide

  Run by

  Queen Silvia Children's Hospital, Gothenburg, Sweden

  See details and how to joinNCT05386173